BARCLAYS PLC

Holdings History for Revance Therapeutics, Inc. - COM (RVNC)

Symbol: RVNC on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024	0%	+0%	$900K	173K	+136,015	+365%	$5.19	Q3 2024
6/30/2024	0%	0%	$95K	37.3K	-2,982,034	-98.8%	$2.55	Q2 2024
3/31/2024	0.01%	+0.01%	$14.9M	3.02M	+2,661,786	+744%	$4.92	Q1 2024
12/31/2023	0%	0%	$3.14M	358K	-176,766	-33.1%	$8.79	Q4 2023
9/30/2023	0%	+0%	$6.13M	534K	+253,564	+90.3%	$11.47	Q3 2023
6/30/2023	0%	+0%	$7.11M	281K	+2,823	+1.02%	$25.31	Q2 2023
3/31/2023	0.01%	0%	$8.95M	278K	-30,629	-9.93%	$32.21	Q1 2023
12/31/2022	0%	+0%	$5.7M	309K	+214,634	+229%	$18.46	Q4 2022
9/30/2022	0%	+0%	$2.54M	93.9K	+48,724	+108%	$27.01	Q3 2022
6/30/2022	0%	+0%	$625K	45.2K	+24,790	+121%	$13.83	Q2 2022
3/31/2022	0%	0%	$398K	20.4K	-88,519	-81.3%	$19.49	Q1 2022
12/31/2021	0%	+0%	$1.78M	109K	+66,856	+159%	$16.32	Q4 2021
9/30/2021	0%	+0%	$1.17M	42.1K	+14,781	+54.1%	$27.85	Q3 2021
6/30/2021	0%	0%	$809K	27.3K	-33,101	-54.8%	$29.64	Q2 2021
3/31/2021	0%	+0%	$1.69M	60.4K	+31,982	+113%	$27.95	Q1 2021
12/31/2020	0%	0%	$805K	28.4K	-5,745	-16.8%	$28.33	Q4 2020
9/30/2020	0%	0%	$859K	34.2K	-2,108	-5.81%	$25.14	Q3 2020
6/30/2020	0%	+0%	$886K	36.3K	+14,060	+63.3%	$24.43	Q2 2020
3/31/2020	0%	0%	$329K	22.2K	-33,017	-59.8%	$14.81	Q1 2020
12/31/2019	0%	+0%	$896K	55.2K	+18,944	+52.2%	$16.22	Q4 2019
9/30/2019	0%	0%	$471K	36.3K	-5,220	-12.6%	$12.98	Q3 2019
6/30/2019	0%	+0%	$538K	41.5K	+8,026	+24%	$12.96	Q2 2019
3/31/2019	0%	+0%	$529K	33.5K	+17,260	+106%	$15.80	Q1 2019
12/31/2018	0%	0%	$326K	16.2K	-11,181	-40.8%	$20.10	Q4 2018
9/30/2018	0%	+0%	$682K	27.4K	+14,988	+121%	$24.89	Q3 2018
6/30/2018	0%	0%	$341K	12.4K	-13,540	-52.2%	$27.48	Q2 2018
3/31/2018	0%	+0%	$800K	26K	+6,814	+35.6%	$30.83	Q1 2018
12/31/2017	0%	+0%	$684K	19.1K	+7,417	+63.3%	$35.74	Q4 2017
9/30/2017	0%	+0%	$322K	11.7K	+564	+5.06%	$27.48	Q3 2017
6/30/2017	0%	0%	$294K	11.2K	-8,857	-44.3%	$26.36	Q2 2017
3/31/2017	0%	+0%	$416K	20K	+11,930	+148%	$20.79	Q1 2017
12/31/2016	0%	+0%	$168K	8.08K	+7,683	+1926%	$20.79	Q4 2016
9/30/2016	0%	0%	$6K	399	-3,041	-88.4%	$15.04	Q3 2016
6/30/2016	0%	+0%	$47K	3.44K	+3,298	+2323%	$13.66	Q2 2016
3/31/2016			$1K	33			$30.30^*	Q1 2016
3/31/2016	0%	0%	$2K	142	-311	-68.7%	$14.08	Q1 2016
12/31/2015	0%	0%	$15K	453	-34,569	-98.7%	$33.11	Q4 2015
9/30/2015	0%	+0%	$1.02M	35K	+34,642	+9116%	$29.01	Q3 2015
6/30/2015	0%	0%	$12K	380	-4,007	-91.3%	$31.58	Q2 2015
3/31/2015	0%	+0%	$88K	4.39K	+3,896	+793%	$20.06	Q1 2015
12/31/2014	0%	+0%	$8K	491	+380	+342%	$16.29	Q4 2014
9/30/2014	0%	0%	$2K	111	-1,868	-94.4%	$18.02	Q3 2014
6/30/2014	0%	+0%	$67K	1.98K	+1,791	+953%	$33.86	Q2 2014
3/31/2014	0%	+0%	$6K	188	+188	NEW	$31.91	Q1 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.